Concepedia

Robert Knight

RK

Statistics

Publications

130

Citations

20.4K

H-Index

52

Active since

1985

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Dana-Farber Cancer Institute

Moffitt Cancer Center

Cornell University

National and Kapodistrian University of Athens

Robert Knight is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, hematologic malignancy therapy, and lenalidomide therapy.

ORCID

Publications per year

1985–2021

130

Publications

130

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia

Eytan M. Stein, Courtney D. DiNardo, Daniel A. Pollyea et al. · Blood · 2017 · 1.5K citations · Full text

, , +13

Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma

Meletios Α. Dimopoulos, Andrew Spencer, Michael Attal et al. · New England Journal of Medicine · 2007 · 1.5K citations

, , +14

Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion

Alan F. List, Gordon W. Dewald, John M. Bennett et al. · New England Journal of Medicine · 2006 · 1.3K citations

, , +17

Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America

Donna M. Weber, Christine Chen, Rubén Niesvizky et al. · New England Journal of Medicine · 2007 · 1.2K citations · Full text

, , +14

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

James R. Berenson, Alan Lichtenstein, Lester Porter et al. · New England Journal of Medicine · 1996 · 1.1K citations

, , +16

1–5 of 130